Yuanbo Xue

Chinese PLA General Hospital — China

Medicine · Health Sciences

12h-index670citations20works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(4), Epigenetics and DNA Methylation(3), Immunotherapy and Immune Responses(3), PI3K/AKT/mTOR signaling in cancer(3), Lung Cancer Treatments and Mutations(2)

Publications20 total

Comparison of pathological complete response (pCR) between short-term (<6 cycles) and long-term (≥6 cycles) neoadjuvant trastuzumab therapy for HER2-positive breast cancer: a systematic review and meta-analysis of randomized controlled trials
Gland Surgery·2025Open Access
A Fingerprint Collection and Enhancement Method for Indoor Localization
2023· 1 cited
Correction: Liu et al. Failure Characteristics of the Water-Resisting Coal Pillar under Stress-Seepage Coupling and Determination of Reasonable Coal Pillar Width. Water 2023, 15, 1002
Water·2023Open Access
Failure Characteristics of the Water-Resisting Coal Pillar under Stress-Seepage Coupling and Determination of Reasonable Coal Pillar Width
Water·2023· 17 citedOpen Access
PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway
International Journal of Oncology·2022· 7 citedOpen Access
Randomized, Multicenter, Open-Label Trial of Autologous Cytokine-Induced Killer Cell Immunotherapy Plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
SSRN Electronic Journal·2020Open Access
A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma
Technology in Cancer Research & Treatment·2020· 16 citedOpen Access
Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis
Biomedicine & Pharmacotherapy·2019· 47 citedOpen Access
HDGF and PRKCA upregulation is associated with a poor prognosis in patients with lung adenocarcinoma
Oncology Letters·2019· 29 citedOpen Access
Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis
OncoImmunology·2019· 270 citedOpen Access
SHIP1 inhibits cell growth, migration, and invasion in non‑small cell lung cancer through the PI3K/AKT pathway
Oncology Reports·2019· 20 citedOpen Access
Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation <i>in vitro</i> and in nude mouse xenografts
Bioengineered·2019· 13 citedOpen Access
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
BMC Cancer·2017· 44 citedOpen Access
Erratum to: NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin
Journal of Hematology & Oncology·2016· 1 citedOpen Access
NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin
Journal of Hematology & Oncology·2015· 46 citedOpen Access
miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer
American Journal Of Pathology·2015· 35 citedOpen Access
miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway
Oncotarget·2015· 74 citedOpen Access
Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro
Cytokine·2014· 42 cited
Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma
Autoimmunity·2013· 8 cited
Progresses on the methods of tumor chromosome aberration analysis
Hereditas (Beijing)·2009

Frequent Co-authors

Ruilei Li(13), Chunlei Ge(10), Xin Song(10), Suwei Dong(7), Qiaofen Fu(5), Zhimin Liu(5), Jinyan Yang(5), Baozhen Zeng(4), Zhen Li(4), Chunlei Ge(3), Ying Wang(3), Tan Qing-hua(3), Zhangchao Lai(3), Jiyin Guo(3), Xin Song(2), Weiwei Wang(2), Zhiwei Zhang(2), Liang Zeng(2), Ying-Ying Zou(2), Gaofeng Li(2)